Pharmacology Programme
Matrix of learning outcomes versus course outcomes
| All Courses in the Program | Program Competencies | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EFR605 LITERATURE EVALUATION IN PHARMACOLOGY I | 1 | 1 | 5 | 4 | 1 | 1 | 4 | 5 | 5 | 5 | 1 | 3 |
| EFR609 GENERAL PHARMACOLOGY | 5 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 4 | 1 | 4 | 4 |
| EFR613 PHARMACOLOGY of CHEMICAL MEDIATORS | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 4 | 1 | 1 | 2 |
| EFR713 INFLAMMATION PHARMACOLOGY | 5 | 1 | 1 | 1 | 1 | 4 | 4 | 5 | 5 | 4 | 2 | 3 |
| EFR606 DRUGS of CENTRAL NERVOUS SYSTEM | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 4 | 1 | 1 | 2 |
| EFR608 DRUGS REGULATING CARDIOVASCULAR FUNCTIONS | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 4 | 1 | 1 | 2 |
| EFR616 SCREENING METHODS IN PHARMACOLOGY | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 5 | 1 | 1 | 1 |
| EFR690 SEMINAR I | 1 | 1 | 4 | 1 | 1 | 1 | 3 | 5 | 5 | 3 | 1 | 1 |
| EFR706 LITERATURE EVALUATION IN PHARMACOLOGY II | 1 | 1 | 5 | 4 | 1 | 1 | 4 | 5 | 5 | 5 | 1 | 3 |
| EFR712 VASCULAR PHARMACOLOGY | 4 | 1 | 1 | 1 | 1 | 4 | 3 | 5 | 5 | 4 | 1 | 3 |
| EFR792 SEMINAR II | 1 | 1 | 4 | 1 | 1 | 1 | 3 | 5 | 5 | 3 | 1 | 1 |
| SBE601 RESEARCH METHODS, RESEARCH and PUBLICATION ETHICS | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 4 |
| EFR600-01 SPECIAL TOPICS I | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 4 | 5 |
| EFR715 SELECTED TOPICS IN CENTRAL NERVOUS SYSTEM | ||||||||||||
| EFR600-02 SPECIAL TOPICS II | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | |